Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Background: Age at diagnosis is incorporated into all relevant staging systems for
differentiated thyroid carcinoma (DTC). There is growing evidence that a specific age cutoff …

Patient's age at the time of diagnosis is an important prognostic factor for differentiated
thyroid cancer (DTC) as reflected in various staging and risk stratification systems. However …

Background: The 2015 American Thyroid Association (ATA) guidelines proposed a three-
category system for estimating the risk of recurrence of differentiated thyroid carcinoma …

In differentiated thyroid carcinoma 10-year survival rates amount to 80–95%. Because age
at diagnosis varies widely, these survival rates strongly depend on age at presentation. The …

Objective To determine the impact of age on disease-specific survival in differentiated
thyroid cancer. Study Design Retrospective analysis of a large population database. Setting …

Background Age 45 years is used as a cutoff in the staging of well-differentiated thyroid
cancer (WDTC) as it represents the median age of most datasets. The aim of this study was …

A retrospective analysis of tumour and patient characteristics was performed in 202 patients
with papillary (n= 132) or follicular (n= 70) thyroid carcinoma, in order to identify prognostic …

Purpose Patient age is considered to play a unique prognostic role in papillary thyroid
cancer (PTC), with a distinct staging dichotomization at 45 years of age. This is based on …

Context Age at diagnosis has been identified as a major determinant of thyroid cancer–
specific survival, with older patients being at higher risk for mortality, but the association of …